Tuesday, April 20, 2010

Study shows risks, benefits of tamoxifen, Evista for preventing breast cancer

MILWAUKEE - Older women at higher risk for breast cancer now have two good drug options for preventing the disease, but they will have to weigh the trade-offs, a major study shows. Tamoxifen, the longtime gold standard, is more effective and longer lasting, the results show....More

No comments: